|Age:||18 - 75|
|Keywords:||Atopic dermatitis, Eczema|
|Type:||Phase 2, Drug Study|
Participation in the study may last up to approximately 41 weeks with up to 15 visits to the study clinic.
Other eligibility criteria will be determined during the initial clinic visit.
Who CANNOT Participate: - Pregnant or planning a pregnancy
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.